688192.SS · 迪哲医药
China A-shares · RS rating 93 · As of 2026-10-14
| Price | 60.69 CNY |
|---|---|
| 1-day change | -1.9% |
| RS rating (overall / 1M / 3M / 12M) | 93 / 91 / 94 / 50 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 46 / 46 / 37 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +7.0% |
| Distance from 52-week high | +16.2% |
| Market cap (USD) | $4.1B |